Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Ubs Ag (MVRL) Other Non-Current Liabilities (2016 - 2025)

Historic Other Non-Current Liabilities for Ubs Ag (MVRL) over the last 16 years, with Q2 2025 value amounting to $8.4 billion.

  • Ubs Ag's Other Non-Current Liabilities fell 921.92% to $8.4 billion in Q2 2025 from the same period last year, while for Jun 2025 it was $8.4 billion, marking a year-over-year decrease of 921.92%. This contributed to the annual value of $11.9 billion for FY2024, which is 7825.5% up from last year.
  • Per Ubs Ag's latest filing, its Other Non-Current Liabilities stood at $8.4 billion for Q2 2025, which was down 921.92% from $8.0 billion recorded in Q1 2025.
  • Ubs Ag's Other Non-Current Liabilities' 5-year high stood at $11.9 billion during Q4 2024, with a 5-year trough of $5757.0 in Q3 2022.
  • For the 5-year period, Ubs Ag's Other Non-Current Liabilities averaged around $5.9 billion, with its median value being $6.5 billion (2021).
  • Within the past 5 years, the most significant YoY rise in Ubs Ag's Other Non-Current Liabilities was 10545953602.43% (2022), while the steepest drop was 9999.99% (2022).
  • Quarter analysis of 5 years shows Ubs Ag's Other Non-Current Liabilities stood at $8572.0 in 2021, then soared by 105459536.02% to $9.0 billion in 2022, then fell by 26.08% to $6.7 billion in 2023, then surged by 78.26% to $11.9 billion in 2024, then decreased by 29.23% to $8.4 billion in 2025.
  • Its last three reported values are $8.4 billion in Q2 2025, $8.0 billion for Q1 2025, and $11.9 billion during Q4 2024.